scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1038437058 |
P356 | DOI | 10.1186/1471-2407-13-22 |
P8608 | Fatcat ID | release_nvdqa2xb6zgc7nacq43qsfdn4u |
P932 | PMC publication ID | 3722081 |
P698 | PubMed publication ID | 23324131 |
P5875 | ResearchGate publication ID | 234156751 |
P50 | author | Lorenzo Spaggiari | Q63437485 |
P2093 | author name string | Ceccarelli Matteo | |
Ceribelli Anna | |||
Crivellari Gino | |||
DePas Tommaso Martino | |||
Facciolo Francesco | |||
Favaretto Adolfo | |||
Kazeem Gbenga | |||
Marchi Paolo | |||
Marulli Giuseppe | |||
Paccagnella Adriano | |||
Rea Federico | |||
Russo Francesca | |||
Spaggiari Lorenzo | |||
P2860 | cites work | Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma | Q34214330 |
Advances in malignant mesothelioma | Q34459139 | ||
Malignant mesothelioma: options for management | Q35020407 | ||
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study | Q35141809 | ||
Pemetrexed and malignant pleural mesothelioma | Q36522672 | ||
Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma | Q36822118 | ||
Future developments in the management of malignant pleural mesothelioma | Q37449036 | ||
Malignant pleural mesothelioma: current treatments and emerging drugs. | Q37529848 | ||
Radiotherapy in malignant pleural mesothelioma | Q37593248 | ||
Multimodality strategies in malignant pleural mesothelioma | Q37613234 | ||
Trimodality therapy for malignant pleural mesothelioma: results from an EORTC phase II multicentre trial. | Q43043845 | ||
The MARS feasibility trial: conclusions not supported by data | Q46905759 | ||
Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma | Q80147152 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | cisplatin | Q412415 |
phase II clinical trial | Q42824440 | ||
P304 | page(s) | 22 | |
P577 | publication date | 2013-01-16 | |
P1433 | published in | BMC Cancer | Q326300 |
P1476 | title | Phase II trial of neoadjuvant pemetrexed plus cisplatin followed by surgery and radiation in the treatment of pleural mesothelioma | |
P478 | volume | 13 |
Q58804842 | Adjuvant, neoadjuvant, and definitive radiation therapy for malignant pleural mesothelioma |
Q60928995 | Biodistribution and Tumor Uptake of Ga-Nimotuzumab in a Malignant Pleural Mesothelioma Xenograft |
Q59137556 | Combined modality treatment in mesothelioma: a systemic literature review with treatment recommendations |
Q27908468 | Consensus report of the 2015 Weinman International Conference on Mesothelioma |
Q64882003 | Defining the role of adjuvant radiotherapy for malignant pleural mesothelioma: a propensity-matched landmark analysis of the National Cancer Database. |
Q64080942 | Extra-pleural pneumonectomy |
Q34130373 | Extrapleural pneumonectomy or pleurectomy/decortication for malignant pleural mesothelioma |
Q41262195 | Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Toxicity and outcomes at an Australian institution |
Q38255347 | Local and systemic therapies for malignant pleural mesothelioma |
Q36417109 | Long-term results in malignant pleural mesothelioma treated with neoadjuvant chemotherapy, extrapleural pneumonectomy and intensity-modulated radiotherapy |
Q38215513 | Management of malignant pleural mesothelioma-The European experience |
Q40354488 | Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial |
Q50049398 | Predictors of trimodality therapy and trends in therapy for malignant pleural mesothelioma |
Q89889132 | Prolonged Progression-Free Survival in a Patient With Malignant Pleural Mesothelioma Following Korean Herbal Medicine Treatment Alone: A Case Report |
Q64234040 | Prolonged post-recurrence survival following pleurectomy/decortication for malignant pleural mesothelioma |
Q40223042 | Propensity matched comparison of extrapleural pneumonectomy and pleurectomy/decortication for mesothelioma patients†. |
Q50200696 | Radiotherapy for the treatment of malignant pleural mesothelioma |
Q40294287 | Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma |
Q89390949 | Scientific Advances and New Frontiers in Mesothelioma Therapeutics |
Q38195607 | Surgical management of malignant pleural mesothelioma: impact of surgery on survival and quality of life-relation to chemotherapy, radiotherapy, and alternative therapies. |
Q89502927 | The Role of Neoadjuvant Chemotherapy in Patients with Resectable Malignant Pleural Mesothelioma - An Institutional and National Analysis |
Q38599311 | The role of radical radiotherapy in the management of malignant pleural mesothelioma: A systematic review |
Q37128016 | Which type of surgery should become the preferred procedure for malignant pleural mesothelioma: extrapleural pneumonectomy or extended pleurectomy? |